Aveanna Healthcare (NASDAQ:AVAH) CEO Sells $1,035,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 90,000 shares of the business’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $1,035,000.00. Following the completion of the transaction, the chief executive officer directly owned 2,561,972 shares in the company, valued at $29,462,678. This represents a 3.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Aveanna Healthcare Stock Up 0.2%

AVAH stock opened at $13.62 on Thursday. Aveanna Healthcare Holdings Inc. has a one year low of $5.93 and a one year high of $13.98. The stock has a market capitalization of $2.97 billion, a PE ratio of 11.07, a price-to-earnings-growth ratio of 0.85 and a beta of 1.90. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. The company has a fifty day moving average of $9.95 and a 200-day moving average of $8.03.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings results on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.05. The business had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. As a group, analysts expect that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Barclays raised their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a report on Thursday, July 9th. Royal Bank Of Canada upped their price objective on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a report on Monday. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. Truist Financial boosted their target price on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday. Finally, Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $12.89.

Institutional Investors Weigh In On Aveanna Healthcare

Several institutional investors have recently modified their holdings of AVAH. AQR Capital Management LLC increased its stake in Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after purchasing an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in Aveanna Healthcare by 8.3% in the first quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock valued at $1,842,000 after purchasing an additional 25,974 shares during the last quarter. Jane Street Group LLC grew its holdings in Aveanna Healthcare by 522.0% in the first quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock valued at $407,000 after purchasing an additional 63,010 shares during the last quarter. Creative Planning increased its position in shares of Aveanna Healthcare by 15.1% in the second quarter. Creative Planning now owns 47,025 shares of the company’s stock valued at $246,000 after buying an additional 6,171 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Aveanna Healthcare by 65.0% in the second quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock valued at $828,000 after buying an additional 62,348 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.